Skip to content
Screener

Viatris VTRS Accrued Expenses

Accrued Expenses at other companies

McKesson logo
McKessonMCK
$5.04B+2.3%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$27.15M-17.5%
Cencora logo
CencoraCOR
$3.35B
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$2.07M-5.5%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
$592K
Scilex Holding Company logo
Scilex Holding CompanySCLX
$255K-99.8%

Other financials

Income statement

See full
Revenue$3.8B+4.9%
Gross profit$1.5B+9.3%
Operating income$6.3M-97.3%
Net income-$118.8M-2,483%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$890.0M+56.7%
Total debt$13.6B-7.7%
Total equity$14.3B-8.4%
Total assets$35.0B-8.8%

Cash flow

See full
Operating cash flow$381.8M+73.8%
CapEx$52.8M-0.2%
Free cash flow$329.0M+97.2%

Valuation

See full
Market cap$20.55B+100%
Enterprise value$33.29B+36.1%
P/S1.4×+0.7×

Profitability

See full
Gross margin34.8%-1.8pp
Operating margin-0.6%
Net margin-2.8%-1.3pp
FCF margin13.3%+0.9pp

Returns & leverage

See full
Return on equity-2.8%-1.3pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The source filing: Viatris’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001792044-26-000041
(In millions)June 30,2026December 31, 2025
Accrued sales allowances$899.7$1,011.2
Payroll and employee benefit liabilities600.7756.4
Legal and professional accruals, including litigation accruals303.0326.3
Contingent consideration18.928.5
Accrued restructuring52.240.2
Accrued interest43.852.9
Fair value of financial instruments101.2166.6
Operating lease liability115.3109.4

ITEM 6. [Exhibits](#i61e5533529bd4b8b8b580f5cad6a41ec_190) [74](#i61e5533529bd4b8b8b580f5cad6a41ec_190)

FAQ

What is Viatris's accrued expenses?
Viatris (VTRS) reported accrued expenses of $600.7M in Q2 2026.
How has Viatris's accrued expenses changed year-over-year?
Viatris's accrued expenses increased by 5.8% year-over-year, from $567.8M to $600.7M.
What is the long-term trend for Viatris's accrued expenses?
Over 5 years (2020 to 2025), Viatris's accrued expenses has grown at a -31.3% compound annual growth rate (CAGR), from $4.96B to $756.4M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Viatris's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude